Longboard Pharmaceuticals, Inc. logo

Longboard Pharmaceuticals, Inc.

NASDAQ:LBPH

Overview | Financials
Company Name Longboard Pharmaceuticals, Inc.
Symbol LBPH
Currency USD
Price 34.32
Market Cap 1,335,031,526
Dividend Yield 0%
52-week-range 3.6 - 40.48
Industry Biotechnology
Sector Healthcare
CEO Mr. Kevin R. Lind
Website https://www.longboardpharma.com

An error occurred while fetching data.

About Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which

Related Stocks

eFFECTOR Therapeutics, Inc. logo

eFFECTOR Therapeutics, Inc.

EFTR

0.04 USD

LENSAR, Inc. logo

LENSAR, Inc.

LNSR

5.06 USD

Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc.

PYXS

3.78 USD

Financials

Numbers are in millions USD

Numbers are in millions USD